JPMorgan raises Macquarie Group stock price target on strong results By Investing.com

JPMorgan raised Macquarie Group’s price target to AUD265 from AUD240 and kept an Overweight rating, citing stronger-than-expected second-half FY2026 results and brighter divisional guidance. The firm now models about 3% group NPAT growth in FY2027 and a 5% three-year NPAT CAGR, while noting the stock trades at 17.7x forward P/E versus a cheaper-than-history valuation. The article also highlights mixed broker views, with Goldman Sachs cutting to Sell and Jefferies initiating Buy, underscoring a constructive but still contested outlook.

Analysis

The key signal is not the target increase itself, but the implied inflection in earnings quality: better mix, less drag from stranded capital, and a cleaner path for capital return. For diversified financials, the market usually underwrites the sum-of-the-parts only when recurring fee and market-linked revenues can offset the volatility in principal investing; this read-through says Macquarie may be moving back toward that regime, which can justify a higher multiple even if headline EPS growth stays mid-single digits.

The second-order winner is the broader asset- and infrastructure-adjacent ecosystem: when a platform like this re-accelerates, it tends to pull through activity in M&A advisory, capital raising, and secondary monetizations across the mid-cap complex. That is supportive for brokers, alternative managers, and transaction-heavy banks with leverage to deal volume, while the losers are valuation-sensitive defensives that have benefited from the prior compression in financials volatility.

The risk is that the market is extrapolating a cyclical rebound into something more durable than it is. If commodity trading, realizations, or one-off sale gains normalize faster than expected, the stock can de-rate quickly because a 17-18x forward multiple already prices in a decent amount of improvement; the left-tail is a year where trading activity cools and impairments reappear, compressing the upgrade cycle before it matures.

Consensus may still be underestimating how much operating leverage sits below the surface if tax and non-recurrence effects line up for another 2-3 reporting periods. But after a strong rerating, the asymmetry shifts from chasing the stock outright to expressing relative value versus peers that have less earnings cyclicality but also less upside surprise potential.

Key Decisions for Investors

• Go long JPM on a 3-6 month horizon as the cleaner U.S. read-through from stronger financials mix and improved capital markets activity; target 8-12% upside from estimate revisions, with downside limited if rates stay stable.
• Initiate a relative-value short GS / long JPM pair for 1-2 quarters: the article reinforces dispersion in analyst conviction, and JPM’s more constructive earnings path should outperform if financials rerate on upgrades.
• For Australia exposure, buy MQG on pullbacks only, not strength; use a 5-7% retracement entry with a 6-9 month view, since the current setup is more about momentum plus upgrades than pristine valuation support.
• If already long MQG, finance downside with a 3-6 month put spread rather than outright trimming; implied volatility should remain elevated around earnings revisions, and protection is cheap relative to the stock’s recent run.
• Add a basket long to financials-activity beneficiaries versus low-beta defensives for the next 1-2 quarters, since improving transaction and market activity should favor cyclically levered franchises over bond-proxy equities.